SCOPUS 정보 검색 플랫폼

Volumn 69, Issue 6, 2001, Pages 937-943

Transient expansion of peptide-specific lymphocytes producing IFN-γ after vaccination with dendritic cells pulsed with MAGE peptides in patients with mage-A1/A3-positive tumors

(12) Toungouz, M a Libin, M a Bulte F a Faid, L a Lehmann, F a Duriau, D a Laporte, M a Gangji, D a Bruyns, C a Lambermont, M a Goldman, M a Velu, T a

a ERASME HOSPITAL (Belgium)

Author keywords

Cytokine flow cytometry; ELISPOT; Keyhole limpet hemocyanin; T cell response

Indexed keywords

GAMMA INTERFERON; MELANOMA ANTIGEN 1; MELANOMA ANTIGEN 3; PROTEIN; TUMOR VACCINE; UNCLASSIFIED DRUG;

ADULT; AGED; ANTINEOPLASTIC ACTIVITY; CANCER IMMUNIZATION; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; FEMALE; FLOW CYTOMETRY; HUMAN; LEUKAPHERESIS; MALE; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

ADULT; AGED; ANTIGENS, NEOPLASM; CANCER VACCINES; DENDRITIC CELLS; DISEASE PROGRESSION; FEMALE; HEMOCYANIN; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; INTERFERON TYPE II; MALE; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASMS; PEPTIDE FRAGMENTS; T-LYMPHOCYTE SUBSETS; TREATMENT OUTCOME; VACCINATION;

EID: 0034973615 PISSN: 07415400 EISSN: None Source Type: Journal
DOI: None Document Type: Conference Paper

Times cited : (56)

References (25)

1
- 0030848161
- Induction of a CD8+ cytotoxic T lymphocyte response by cross-priming requires cognate CD4+ T cell help
- (1997) J. Exp. Med. , vol.186 , pp. 65-70
- Bennett, S.R.M.¹ Carbone, F.² Karamalis, F.³ Miller, J.F.A.P.⁴ Heath, W.R.⁵

2
- 0032433127
- The central role of CD4+ T cells in the anti-tumor immune response
- (1998) J. Exp. Med. , vol.188 , pp. 2357-2368
- Hung, K.¹ Hayashi, R.² Lafond-Walker, A.³ Lowenstein, C.⁴ Pardoll, D.⁵ Levistky, H.⁶

3
- 0034650421
- CD4+ T cells control of CD8+ T cell reactivity to a model tumor antigen
- (2000) J. Immunol. , vol.164 , pp. 562-565
- Surman, D.R.¹ Dudley, M.E.² Overwijk, W.W.³ Restifo, N.P.⁴

4
- 0029935569
- Enhanced tumor outgrowth after peptide vaccination: Functional deletion of tumor-specific CTL induced by peptide vaccination can lead to the inability to reject tumors
- (1996) J. Immunol. , vol.156 , pp. 3911-3918
- Toes, R.E.M.¹ Blom, R.J.J.² Offringa, R.³ Kast, W.M.⁴ Melief, C.J.M.⁵

5
- 0032080385
- Enhancement of tumor outgrowth through CTL tolerization after peptide vaccination is avoided by peptide presentation on dendritic cells
- (1998) J. Immunol. , vol.160 , pp. 4449-4456
- Toes, R.E.M.¹ Van der Voort, H.² Scheonberger, S.P.³ Drijfhout, J.W.⁴ Van Bloois, L.⁵ Storm, G.⁶ Kast, W.M.⁷ Offringa, R.⁸ Melief, C.J.M.⁹

6
- 21544470687
- Generation of immature autologous clinical grade dendritic cells for vaccinatio of cancer patients
- (1999) Cytotherapy , vol.1 , pp. 447-453
- Toungouz, M.¹ Quinet, C.² Thille, E.³ Fourez, S.⁴ Pradier, O.⁵ Delville, J.P.⁶ Velu, T.⁷ Lambermont, M.⁸

7
- 0032918091
- Migration of human dendritic cells after injection in patients with metastatic malignancies
- (1999) Cancer Res. , vol.59 , pp. 56-58
- Morse, M.A.¹ Coleman, R.E.² Akabani, G.³ Niehaus, N.⁴ Coleman, D.⁵ Lyerly, H.K.⁶

8
- 0032529216
- TCR ligation on CD8+ T cells creates double-negative cells in vivo
- (1998) J. Immunol. , vol.161 , pp. 1686-1693
- Mehal, W.J.¹ Crispe, I.N.²

9
- 0032953409
- Retrovirally transuced bone marrow-derived dendritic cells require CD4+ T cell help to elicit protective and therapeutic antitumor immunity
- (1999) J. Immunol. , vol.162 , pp. 144-151
- De Veerman, M.¹ Heirman, C.² Van Meirvenne, S.³ Devos, S.⁴ Corthals, J.⁵ Moser, M.⁶ Thielemans, K.⁷

10
- 0031890206
- Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma
- (1998) Nat. Med. , vol.4 , pp. 321-327
- Rosenberg, S.A.¹ Yang, J.C.² Schwartzenruber, D.J.³ Hwu, P.⁴ Marincola, F.M.⁵ Topalian, S.⁶ Restifo, N.⁷ Dudley, M.E.⁸ Swharz, S.⁹ Spiess, P.¹⁰ Wunderlich, J.R.¹¹ Parkhust, M.R.¹² Kawakami, Y.¹³ Seipp, C.A.¹⁴ Einhorn, J.H.¹⁵ White, D.E.¹⁶

11
- 0031941423
- Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells
- (1998) Nat. Med. , vol.4 , pp. 328-332
- Nestle, F.O.¹ Alijagic, S.² Gilliet, M.³ Sun, Y.⁴ Grabbe, S.⁵ Dummer, R.⁶ Burg, G.⁷ Schadendorf, D.⁸

12
- 0030026776
- Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells
- (1996) Nat. Med. , vol.2 , pp. 52-58
- Hsu, F.J.¹ Benike, C.² Fagnoni, F.³ Liles, T.M.⁴ Czerwinski, D.⁵ Taidi, B.⁶ Engleman, E.G.⁷ Levy, R.⁸

13
- 0030470404
- Phase I clinical trial: T-cell therapy for prostate cancer using autologous dendritic cells pulsed with HLA-A0201-specific peptides from prostate-specific membrane antigen
- (1996) Prostate , vol.29 , pp. 371-380
- Murphy, G.¹ Tjoa, B.² Ragde, H.³ Kenny, G.⁴ Boynton, A.⁵

14
- 0030858138
- Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells
- (1997) Nature , vol.388 , pp. 782-787
- Cella, M.¹ Engering, A.² Pinet, V.³ Pieters, J.⁴ Lanzavecchia, A.⁵

15
- 0032080187
- Differential deactivation of human dendritic cells by endotoxin desentization: Role of tumor necrosis factor-α and prostaglandin E2
- (1998) Blood , vol.91 , pp. 3112-3117
- Rieser, C.¹ Papesh, C.² Herold, M.³ Böck, G.⁴ Ramoner, R.⁵ Klocker, H.⁶ Bartsch, G.⁷ Thurnher, M.⁸

16
- 0033405438
- Vaccination with MAGE-3.A1 peptide-pulsed mature monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma
- (1999) J. Exp. Med. , vol.190 , pp. 1669-1678
- Thurner, B.¹ Haendle, I.² Roder, C.³ Dieckmann, D.⁴ Keikavoussi, P.⁵ Jonuleit, H.⁶ Bender, A.⁷ Maczek, C.⁸ Schreiner, D.⁹ Von den Driesch, P.¹⁰ Brocker, E.B.¹¹ Steinman, R.M.¹² Enk, A.¹³ Kampgen, E.¹⁴ Schuler, G.¹⁵

17
- 1842296989
- Analysis of MAGE-3-specific cytolytic T lymphocytes in human leucocyte antigen-A2 melanoma patients
- (1997) Cancer Res. , vol.57 , pp. 735-741
- Valmori, D.¹ Lienard, D.² Waanders, G.³ Rimoldi, D.⁴ Cerottinin, J.C.⁵ Romero, P.⁶

18
- 0031874257
- Estimation of the frequencies of anti-MAGE-3 cytolytic T-lymphocytes precursors in blood from individuals without cancer
- (1998) Int. J. Cancer , vol.77 , pp. 538-542
- Chaux, P.¹ Vantomme, V.² Coulie, P.³ Boon, T.⁴ Van der Bruggen, P.⁵

19
- 0032482158
- A new look at T cells
- (1998) J. Exp. Med. , vol.187 , pp. 1367-1371
- McMichael, A.J.¹ O'Callaghan, C.A.²

20
- 0029743737
- Direct visualization and phenotypic analysis of virus-specific T lymphocytes in HIV-infected individuals
- (1996) Science , vol.274 , pp. 94-96
- Altman, J.¹ Moss, P.A.H.² Goulder, P.J.R.³ Baroush, D.H.⁴ McHeyzer-Williams, M.G.⁵ Bell, J.I.⁶ McMichael, A.J.⁷ Davis, M.M.⁸

21
- 0027403718
- Quantitative analysis of the human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocytes (CTL) response at different stages of HIV-1 infection: Differential CTL responses to HIV-1 and Epstein-Bart virus in late disease
- (1993) J. Exp. Med. , vol.177 , pp. 249-256
- Carmichael, A.¹ Jin, X.² Sissons, P.³ Borysiewicz, L.⁴

22
- 0029642252
- Tumor regression responses in melanoma patients treated with a peptide encoded by gene MAGE-3
- (1995) Int. J. Cancer , vol.63 , pp. 883-885
- Marchant, M.¹ Weynants, P.² Rankin, E.³ Arienti, F.⁴ Belli, F.⁵ Parmiani, G.⁶ Cascinelli, N.⁷ Bourlond, A.⁸ Vanwijck, R.⁹ Humblet, Y.¹⁰ Canon, J.L.¹¹ Laurent, C.¹² Naeyaert, J.M.¹³ Plagne, R.¹⁴ Deraemaeker, R.¹⁵ Knuth, A.¹⁶ Jäger, E.¹⁷ Brasseur, F.¹⁸ Herman, J.¹⁹ Coulie, P.G.²⁰ Boon, T.²¹ more..

23
- 0033103512
- Identification of MAGE-3 epitopes presented by HLA-DR molecules to CD4+ T lymphocytes
- (1999) J. Exp. Med. , vol.189 , pp. 767-777
- Chaux, P.¹ Vantomme, V.² Stroobant, V.³ Thielemans, K.⁴ Corthals, J.⁵ Luiten, R.⁶ Eggermont, A.M.M.⁷ Boon, T.⁸ Van der Bruggen, P.⁹

24
- 0033103147
- Biochemical identification of a mutated human melanoma antigen recognized by CD4+ T cells
- (1999) J. Exp. Med. , vol.189 , pp. 757-765
- Pieper, R.¹ Christian, R.E.² Gonzales, M.I.³ Nishimura, M.I.⁴ Gupta, G.⁵ Settlage, R.E.⁶ Shabanowitz, J.⁷ Rosenberg, S.A.⁸ Hunt, D.F.⁹ Topalian, S.L.¹⁰

25
- 0033103192
- Melanoma cells present a MAGE-3 epitope to CD4+ cytotoxic T cells in association with histocompatibility leukocyte antigen DR11
- (1999) J. Exp. Med. , vol.189 , pp. 871-876
- Manici, S.¹ Sturniolo, T.² Imro, M.A.³ Hammer, J.⁴ Sinigaglia, F.⁵ Noppen, C.⁶ Spagnoli, G.⁷ Mazzi, B.⁸ Bellone, M.⁹ Dellabona, P.¹⁰ Protti, M.P.¹¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.